![Sanfilippo syndrome: consensus guidelines for clinical care | Orphanet Journal of Rare Diseases | Full Text Sanfilippo syndrome: consensus guidelines for clinical care | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-022-02484-6/MediaObjects/13023_2022_2484_Fig1_HTML.png)
Sanfilippo syndrome: consensus guidelines for clinical care | Orphanet Journal of Rare Diseases | Full Text
![Outcomes of a Physician Survey on the Type, Progression, Assessment, and Treatment of Neurological Disease in Mucopolysaccharidoses - Maurizio Scarpa, Paul R. Harmatz, Bianca Meesen, Roberto Giugliani, 2018 Outcomes of a Physician Survey on the Type, Progression, Assessment, and Treatment of Neurological Disease in Mucopolysaccharidoses - Maurizio Scarpa, Paul R. Harmatz, Bianca Meesen, Roberto Giugliani, 2018](https://journals.sagepub.com/cms/10.1177/2326409818759370/asset/images/large/10.1177_2326409818759370-fig3.jpeg)
Outcomes of a Physician Survey on the Type, Progression, Assessment, and Treatment of Neurological Disease in Mucopolysaccharidoses - Maurizio Scarpa, Paul R. Harmatz, Bianca Meesen, Roberto Giugliani, 2018
![Diagnostics | Free Full-Text | Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know Diagnostics | Free Full-Text | Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know](https://www.mdpi.com/diagnostics/diagnostics-13-00075/article_deploy/html/images/diagnostics-13-00075-g001.png)
Diagnostics | Free Full-Text | Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know
![Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review | Published Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review | Published](https://s3.amazonaws.com/production.scholastica/attachment/97049/large/fig4b.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAQP35HG4CYCAIE5XO%2F20230510%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20230510T011731Z&X-Amz-Expires=604800&X-Amz-SignedHeaders=host&X-Amz-Signature=cec368ca341e36851e2a4f8c8850d6ca9e209d88d58aae24dabc6dc53e2db50f)
Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review | Published
![Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future | Journal of Human Genetics Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future | Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs10038-019-0662-9/MediaObjects/10038_2019_662_Fig1_HTML.png)
Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future | Journal of Human Genetics
![IJMS | Free Full-Text | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder? IJMS | Free Full-Text | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?](https://www.mdpi.com/ijms/ijms-23-04854/article_deploy/html/images/ijms-23-04854-g001.png)
IJMS | Free Full-Text | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
![Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II | Orphanet Journal of Rare Diseases | Full Text Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-021-02118-3/MediaObjects/13023_2021_2118_Fig1_HTML.png)
Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II | Orphanet Journal of Rare Diseases | Full Text
![Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II? - Vollebregt - 2021 - Journal of Inherited Metabolic Disease - Wiley Online Library Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II? - Vollebregt - 2021 - Journal of Inherited Metabolic Disease - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/68a81d64-6422-41a6-a8d6-736f1d35b39c/jimd12342-fig-0002-m.jpg)
Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II? - Vollebregt - 2021 - Journal of Inherited Metabolic Disease - Wiley Online Library
![Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/1196987/f/1.png)
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![IJMS | Free Full-Text | Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment IJMS | Free Full-Text | Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment](https://pub.mdpi-res.com/ijms/ijms-21-01258/article_deploy/html/images/ijms-21-01258-ag.png?1583595498)
IJMS | Free Full-Text | Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment
![Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II | Orphanet Journal of Rare Diseases | Full Text Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-021-02118-3/MediaObjects/13023_2021_2118_Fig2_HTML.png)
Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II | Orphanet Journal of Rare Diseases | Full Text
![Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review | Published Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review | Published](https://jheor.org/article/36540-impact-of-the-timing-of-enzyme-replacement-therapy-initiation-and-cognitive-impairment-status-on-outcomes-for-patients-with-mucopolysaccharidosis-ii/attachment/96924.jpeg)
Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review | Published
![Clinical characteristics and genotypes of 201 patients with mucopolysaccharidosis type II in China: A retrospective, observational study - Zhong - Clinical Genetics - Wiley Online Library Clinical characteristics and genotypes of 201 patients with mucopolysaccharidosis type II in China: A retrospective, observational study - Zhong - Clinical Genetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f50de2c4-1904-49ab-afc5-4d3afddb7aba/cge14329-toc-0001-m.jpg?trick=1682708347920)
Clinical characteristics and genotypes of 201 patients with mucopolysaccharidosis type II in China: A retrospective, observational study - Zhong - Clinical Genetics - Wiley Online Library
![Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease | Orphanet Journal of Rare Diseases | Full Text Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1750-1172-6-72/MediaObjects/13023_2011_Article_332_Fig2_HTML.jpg)
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease | Orphanet Journal of Rare Diseases | Full Text
![Frontiers | Neurological, neurobehavioral, and radiological alterations in patients with mucopolysaccharidosis III (Sanfilippo's syndrome) in Brazil Frontiers | Neurological, neurobehavioral, and radiological alterations in patients with mucopolysaccharidosis III (Sanfilippo's syndrome) in Brazil](https://www.frontiersin.org/files/Articles/968297/fneur-13-968297-HTML-r1/image_m/fneur-13-968297-g001.jpg)
Frontiers | Neurological, neurobehavioral, and radiological alterations in patients with mucopolysaccharidosis III (Sanfilippo's syndrome) in Brazil
![Diagnostic algorithm for Hunter syndrome. From (Scarpa et al., 2011,... | Download Scientific Diagram Diagnostic algorithm for Hunter syndrome. From (Scarpa et al., 2011,... | Download Scientific Diagram](https://www.researchgate.net/publication/264391896/figure/fig1/AS:392365362696192@1470558600453/Diagnostic-algorithm-for-Hunter-syndrome-From-Scarpa-et-al-2011-copyright-C-2011.png)
Diagnostic algorithm for Hunter syndrome. From (Scarpa et al., 2011,... | Download Scientific Diagram
![Biomolecules | Free Full-Text | Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement Biomolecules | Free Full-Text | Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement](https://pub.mdpi-res.com/biomolecules/biomolecules-11-00189/article_deploy/html/images/biomolecules-11-00189-ag.png?1612175350)
Biomolecules | Free Full-Text | Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
![Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation - ScienceDirect Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2329050120301972-fx1.jpg)